Reportlinker Adds Gene Therapy – Technologies, Markets and Companies

NEW YORK, March 7, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:

Gene Therapy – technologies, markets and companies

http://www.reportlinker.com/p0203543/Gene-Therapy—technologies-markets-and-companies.html

Summary

Gene therapy can be broadly defined as the transfer of defined
genetic material to specific target cells of a patient for the
ultimate purpose of preventing or altering a particular disease
state. Genes and DNA are now being introduced without the use of
vectors and various techniques are being used to modify the
function of genes in vivo without gene transfer. If one adds to
this the cell therapy particularly with use of genetically modified
cells, the scope of gene therapy becomes much broader. Gene therapy
can now combined with antisense techniques such as RNA interference
(RNAi), further increasing the therapeutic applications. This
report takes broad overview of gene therapy and is the most
up-to-date presentation from the author on this topic built-up from
a series of gene therapy report written by him during the past
decade including a textbook of gene therapy and a book on gene
therapy companies. This report describes the setbacks of gene
therapy and renewed interest in the topic

Gene therapy technologies are described in detail including
viral vectors, nonviral vectors and cell therapy with genetically
modified vectors. Gene therapy is an excellent method of drug
delivery and various routes of administration as well as targeted
gene therapy are described. There is an introduction to
technologies for gene suppression as well as molecular diagnostics
to detect an

‘/>”/>

SOURCE